Ipsen strikes 18-country deal with Probi

27 April 2016 - Deborah Wilkes

Archived

French pharmaceutical company Ipsen has struck a deal covering distribution of Probi's probiotic digestive health capsules in 18 countries, including China, Russia and some European Union member states. The deal contains an option to include additional countries.

Click tags below for more information on topics:

Ipsen

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: